Functional Impact of Acute Respiratory Viral Infections in Older Adults

Part of paid clinical trials in Rochester, New York.

Sponsor
University Hospital, Grenoble
Study ID
NCT07388173
Status
Recruiting

Conditions

  • Respiratory Infections in Old Age

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The prevention of infectious diseases in older adults remains a major public health challenge, as acute respiratory infections are a leading cause of hospitalisation, mortality, and functional decline worldwide. Immunosenescence and environmental exposures increase susceptibility to infection and reduce vaccine effectiveness in this population. Respiratory viruses, including influenza, SARS-CoV-2, respiratory syncytial virus, and human metapneumovirus, account for a substantial share of this burden, much of which is vaccine-preventable. However, their impact on functional decline and recovery in older adults remains insufficiently characterized. This international study aims to assess the effect of hospitalization for major respiratory viral infections on loss of autonomy in individuals aged 60 years and older, to inform targeted prevention and vaccination strategies.

Key Dates

Start date
Jan 15, 2026
Status verified
May 2026
Primary completion
Jan 15, 2028
Completion
Jun 15, 2028

Study Design

Enrollment
1,600 participants (estimated)

Primary Outcome Measure

Evolution of Functional Dependency assessed by Activities of Daily Living (ADL) Score [ Time Frame: Baseline, at hospital discharge, 3 months after discharge, and 6 months after discharge. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Rochester School of Medicine, Infectious Diseases UnitRochesterNew York14642
Edward Walsh, MD PhD

Find similar trials in Rochester, NY